Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Endocrine Metabolic & Immune Disorders - Drug Targets

Improving Immune Checkpoint Therapy in the Tumor Microenvironment by Targeting T Cell Metabolism

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJun WeiBABaozhen AnRDRenchao Dong

Discussion

Loading...

Member takes

Overview

Observational analysis shows metabolic competition hinders T cell activation in the tumor microenvironment, suggesting new therapeutic avenues.

Key Points

  • Increased T cell metabolism is essential for immune function, but competition with tumor cells reduces effectiveness.
  • Limited availability of crucial nutrients like glucose and amino acids impairs T cell proliferation within the tumor microenvironment.
  • Cytokines and immune checkpoints play a significant role in T cell behavior, impacting overall immune response.
  • Modulating tumor and T cell metabolism offers new strategies for enhancing cancer treatment and patient outcomes.

Cite This Study

Wei et al. (2025) studied this question.

synapsesocial.com/papers/68e02f40f0e39f13e7fa29d6https://doi.org/10.2174/0118715303400871250821103310
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Metabolic–immune nexus in tumor microenvironment: From mechanistic insights to therapeutic opportunities2025 · 13 citations
  2. 2Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies2025 · 37 citations
  3. 3Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy2025 · 60 citations
  4. 4Immunometabolism in the Tumor Microenvironment: Dual Role in Modulating Anti-Tumor Immunity and Tumor Progression2025 · 4 citations
  5. 5Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response2025 · 23 citations